Results by group32

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 32

Outcome	Group	Category	Value	Spread	Units
Time to Disease Progression - Median Time to Progression and Log-Rank Test	Arm A: ZD6474 Matched Placebo		5.68	95% Confidence Interval 3.98 to 6.41	Months
Time to Disease Progression - Median Time to Progression and Log-Rank Test	Arm B: ZD6474		5.62	95% Confidence Interval 5.09 to 6.24	Months
Percentage of Participants With Grade 3/4 Hematologic and Non-Hematologic Toxicities	Arm A: ZD6474 Matched Placebo	Grade 3/4 Hematologic Toxicity	11.00		percentage of participants
Percentage of Participants With Grade 3/4 Hematologic and Non-Hematologic Toxicities	Arm B: ZD6474 + Safety Lead-In	Grade 3/4 Hematologic Toxicity	13.75		percentage of participants
Percentage of Participants With Grade 3/4 Hematologic and Non-Hematologic Toxicities	Arm A: ZD6474 Matched Placebo	Grade 3/4 Non-Hematologic Toxicity	2.71		percentage of participants
Percentage of Participants With Grade 3/4 Hematologic and Non-Hematologic Toxicities	Arm B: ZD6474 + Safety Lead-In	Grade 3/4 Non-Hematologic Toxicity	4.30		percentage of participants
Measure the Response Rate (CR + PR) in Each Arm	Arm A: ZD6474 Matched Placebo		65.38	95% Confidence Interval 47.10 to 83.67	percentage of participants
Measure the Response Rate (CR + PR) in Each Arm	Arm B: ZD6474		50.00	95% Confidence Interval 31.48 to 68.52	percentage of participants
Measure Disease Control Rate (CR + PR+ SD) in Each Arm	Arm A: ZD6474 Matched Placebo		73.08	95% Confidence Interval 56.03 to 90.13	percentage of participants
Measure Disease Control Rate (CR + PR+ SD) in Each Arm	Arm B: ZD6474		75.00	95% Confidence Interval 58.96 to 91.04	percentage of participants
Measure Overall Survival for Each Arm	Arm A: ZD6474 Matched Placebo		9.23	95% Confidence Interval 6.64 to 11.27	Months
Measure Overall Survival for Each Arm	Arm B: ZD6474		13.24	95% Confidence Interval 7.82 to 17.38	Months
Assess VEGF Polymorphisms and Correlate Subject Response	Arm A: ZD6474 Matched Placebo	Survival Analysis VEGF SNP rs699947	0.4642		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm B: ZD6474	Survival Analysis VEGF SNP rs699947	0.6148		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm A: ZD6474 Matched Placebo	Survival Analysis VEGF SNP rs3025039	0.1234		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm B: ZD6474	Survival Analysis VEGF SNP rs3025039	0.2050		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm A: ZD6474 Matched Placebo	Survival Analysis VEGF SNP rs2019063	0.3968		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm B: ZD6474	Survival Analysis VEGF SNP rs2019063	0.8486		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm A: ZD6474 Matched Placebo	Survival Analysis VEGF SNP rs1570360	0.0712		probability
Assess VEGF Polymorphisms and Correlate Subject Response	Arm B: ZD6474	Survival Analysis VEGF SNP rs1570360	0.4426		probability

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00613626/results

API reference For AI assistants

Results by group32

Sources 3

Read this list from software.